FDA Inspection 1221203 — Greater Baltimore Medical Center
The FDA completed an inspection of Greater Baltimore Medical Center on October 26, 2023 in Towson, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 26, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Towson, MD (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 18038 | 21 CFR 606.100(b) | SOPs for investigations, records |
| 4425 | 21 CFR 606.60(a) | Equipment observed, standardized, calibrated |